Dr. Gust Bardy, president of the Seattle Institute for Cardiac Research and lead investigator of the Home Automated External Defibrillator Trial (HAT), published in the New England Journal of Medicine, will discuss the use of automated external defibrillators, both at home and in public locations, as a strategy to reduce mortality rates among patients who are at higher risk for sudden cardiac death.
AEDs: Limiting Rates of Sudden Cardiac Death
Share
SaveShare this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Dr. Gust Bardy, president of the Seattle Institute for Cardiac Research and lead investigator of the Home Automated External Defibrillator Trial (HAT), published in the New England Journal of Medicine, will discuss the use of automated external defibrillators, both at home and in public locations, as a strategy to reduce mortality rates among patients who are at higher risk for sudden cardiac death.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?